RDHL News and Press, Redhill Biopharma Ltd. From 12/19/23

GLG Life Tech Corporation (GLGLF) is expected to report for Q1 2024 Accenture plc Class A (Ireland) (ACN) is expected to report $3.14 for Q1 2024 Greenlane Holdings Inc. (GNLN) is expected to report $-2.7 for Q3 2023 iMedia Brands Inc. (IMBIQ) is expected to report for quarter end 202...

2023-12-12 07:05:14 ET More on RedHill RedHill secures funding for Phase 2 study of COVID-19 treatment RedHill stock nearly doubles in value pre-market on a five-year FDA exclusivity grant Financial information for RedHill For further details see: RedHill...

Axcella Health Inc. (AXLA) is expected to report for Q3 2023 Telekom Malaysia Bhd (MYTEF) is expected to report for quarter end 2023-09-30 Atento S.A. (ATTOF) is expected to report for Q3 2023 Scryb Inc Com (SCYRF) is expected to report for Q4 2023 BHP Group Ltd. (BHP) is expected...

2023-12-11 08:32:44 ET Poseida Therapeutics ( PSTX ) +31% Presents Positive Early Results from its Phase 1 Trial of Allogeneic CAR-T P-BCMA-ALLO1 in Relapsed-Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting. Jet. ( JTAI ) +2...

2023-12-07 10:00:03 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Organovo, Fort...

Reliq Health Technologies Inc (RQHTF) is expected to report for quarter end 2023-09-30 Atento S.A. (ATTOF) is expected to report for Q3 2023 GLG Life Tech Corporation (GLGLF) is expected to report for Q1 2024 CMG Holdings Group Inc (CMGO) is expected to report for Q1 2024 Todos Me...

Redhill Biopharma Ltd. (RDHL) is expected to report for Q3 2023

2023-12-04 09:35:58 ET More on RedHill RedHill stock nearly doubles in value pre-market on a five-year FDA exclusivity grant Financial information for RedHill For further details see: RedHill secures funding for Phase 2 study of COVID-19 treatment

RedHill Announces New, Non-Dilutive External Funding of Entire RHB-107 COVID-19 300-Patient Phase 2 Study PR Newswire The new non-dilutive external funding, additional to the previously announced U.S. Government non-dilutive funding, now covers the entirety of the RHB-107 (upa...

2023-11-30 12:33:37 ET Gainers: Smart for Life ( SMFL ) +159% . Immunogen ( IMGN ) +82% . Ampio Pharmaceuticals ( AMPE ) +68% . REX American Resources Corp ( REX ) +36% . ShiftPixy ( PIXY ) +31% . Digital Brands Group ( DBG...